GRAIL, Inc. Other Comprehensive Income (Loss), Net of Tax
GRAIL, Inc. (GRAL) reported Other Comprehensive Income (Loss), Net of Tax of $637.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2025-08-13
- GRAIL, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was $637.00K, a 71.24% increase year-over-year.
- GRAIL, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-03-31 was $215.00K.
- GRAIL, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-06-30 was $372.00K.
- GRAIL, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-03-31 was -$52.00K.
- GRAIL, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $385.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|
| 2025-06-30 | $637.00K 10-Q · filed 2025-08-13 | $852.00K derived: sum of 2 quarters · filed 2025-08-13 | |
| 2025-03-31 | $215.00K 10-Q · filed 2025-08-13 | ||
| 2024-12-31 | $385.00K 10-K · filed 2025-03-05 | ||
| 2024-06-30 | $372.00K 10-Q · filed 2025-08-13 | $320.00K derived: sum of 2 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$52.00K 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |